Why publish with NAR Molecular Medicine?

NAR Molecular Medicine is a cutting-edge new journal in the Nucleic Acids Research family portfolio. The journal is fully open access and publishes quality, impactful original research and critical reviews at the intersection of nucleic acid biology, therapeutics, and the molecular mechanisms of disease.

Broad scope at the intersection of molecular mechanisms of disease and nucleic acids

The journal considers papers within this broad scope from all areas of clinical medicine, pathology, molecular and cellular biology, structure-activity investigations related to disease, computation and drug discovery. Papers may be centered around by not limited to:

Aging
Behavioral and psychological disorders
Cardiovascular, respiratory, hepatic and renal disease
Drug design and vaccines
Endocrinology and metabolic disease
Genetics, epigenetics and gene therapy
Allergy, immunology and immunotherapy
Infectious disease and host-pathogen interactions
Microbiology and antimicrobial therapy
Virology and antiviral therapy
Neurological and neurodegenerative disease
Regenerative medicine
Reproductive biology

Fully open access

Open access (OA) articles are freely available to anyone, which means a broader readership. Researchers, practitioners, and the public can access your work without paywalls or subscriptions. Because of this, OA articles tend to receive more citations, allowing researchers to build on your work and contributing further to scientific progress. Many funding agencies now require the publication of open access research. Publishing with NAR Molecular Medicine ensures that you remain compliant with funders and maximizes the impact of your research.

Oxford University Press has Read and Publish agreements with a large number of institutions and consortia which provide funding for open access publication. Many of our agreements include fully open access journals, either through a discounted APC or through full coverage of the APC. Click here to see if your institution is participating.

NAR Molecular Medicine is run by scientists for scientists

NAR Molecular Medicine is a new journal in well-respected family. As such, you can help us to shape its landscape! Similar to our parent and sister journals, NAR Molecular Medicine’s Editor-in-Chief, Dr. Maria Spies and the Editorial Board members are practicing scientists, who are leaders in the fields encompassing all aspects of DNA and RNA-related research. We are committed to speedy, rigorous and constructive single-anonymized peer review by experienced expert reviewers.

Your experience with the journal will be enhanced at all steps by the help from the editorial staff. Upon acceptance, we will promote your work at the journal home page, that features graphical abstracts, and on social media.

Transfer opportunities amongst the NAR journals family

NAR Molecular Medicine accepts original submissions as well as transfers from Nucleic Acids Research, NAR Cancer and NAR Genomics and Bioinformatics. Preprints in either BioRxiv or MedRxiv can be submitted directly from BioRxiv or MedRxiv to NAR Molecular Medicine.

In some cases, the editorial team of the NAR Molecular Medicine may offer you the option of transferring your manuscript to NAR Cancer or NAR Genomics and Bioinformatics. If you accept this offer, the manuscript files and any reviewer reports from consenting reviewers will be sent to the receiving journal.

Ready to Submit?

Kindly consult our instructions to authors to find detailed information on how to submit your manuscript.